GPCR - Company ID 0001888886
The table below shows Structure Therapeutics Inc.'s income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of revenue | - | - | - | - |
| Gross profit | - | - | - | - |
| R&D | $225.25M | $108.81M | $70.10M | $36.19M |
| SG&A | $61.55M | $49.41M | $32.67M | $16.37M |
| Operating income | -$176.56M | -$158.23M | -$102.78M | -$52.56M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Income tax | $515.00K | $310.00K | $236.00K | $17.00K |
| Net income | -$141.20M | -$122.53M | -$89.62M | -$51.32M |
| EPS (diluted) | -$0.80 | -$0.78 | -$0.81 | -$5.51 |